Ameritas Investment Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $133K | Sell |
|
|||||
|
2025
Q2 | $188K | Hold |
|
|||||
|
2025
Q1 | $157K | Hold |
|
|||||
|
2024
Q4 | $157K | Hold |
|
|||||
|
2024
Q3 | $159K | Buy |
|
|||||
|
2024
Q2 | $116K | Hold |
|
|||||
|
2024
Q1 | $95.7K | Hold |
|
|||||
|
2023
Q4 | $113K | Hold |
|
|||||
|
2023
Q3 | $133K | Buy |
|
|||||
|
2023
Q2 | $104K | Hold |
|
|||||
|
2023
Q1 | $124K | Hold |
|
|||||
|
2022
Q4 | $158K | Buy |
|
|||||
|
2022
Q3 | $175K | Hold |
|
|||||
|
2022
Q2 | $147K | Hold |
|
|||||
|
2022
Q1 | $227K | Hold |
|
|||||
|
2021
Q4 | $193K | Hold |
|
|||||
|
2021
Q3 | $200K | Hold |
|
|||||
|
2021
Q2 | $220K | Sell |
|
|||||
|
2021
Q1 | $153K | Hold |
|
|||||
|
2020
Q4 | $112K | Hold |
|
|||||
|
2020
Q3 | $52K | Buy |
|
|||||
|
2020
Q2 | $61K | Hold |
|
|||||
|
2020
Q1 | $25K | Hold |
|
|||||
|
2019
Q4 | $44K | Buy |
|
|||||
|
2019
Q3 | $24K | Hold |
|
|||||
|
2019
Q2 | $31K | Hold |
|
|||||
|
2019
Q1 | $68K | Hold |
|
|||||
|
2018
Q4 | $67K | Hold |
|
|||||
|
2018
Q3 | $63K | Hold |
|
|||||
|
2018
Q2 | $48K | Hold |
|
|||||
|
2018
Q1 | $40K | Buy |
|
|||||
|
2017
Q4 | $33K | Hold |
|
|||||
|
2017
Q3 | $34K | Hold |
|
|||||
|
2017
Q2 | $37K | Buy |
|
|||||
|
2017
Q1 | $47K | Buy |
|